CV Sciences (CVSI) Return on Capital Employed Growth (1y) (2012 - 2026)
CV Sciences (CVSI) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 1,195.00 |
| 10 | CV Sciences | 3.94 Mn | 3.64 Mn | 1.56 Mn | 1,207.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,207.00 |
| Dec 31, 2025 | -13,464.00 |
| Sep 30, 2025 | -19,782.00 |
| Jun 30, 2025 | 4,414.00 |
| Mar 31, 2025 | 4,500.00 |
| Dec 31, 2024 | 927.00 |
| Sep 30, 2024 | 10,167.00 |
| Jun 30, 2024 | -13,021.00 |
| Mar 31, 2024 | -11,250.00 |
| Dec 31, 2023 | 116,399.00 |
| Sep 30, 2023 | 75,862.00 |
| Jun 30, 2023 | 48,752.00 |
| Mar 31, 2023 | 43,163.00 |
| Dec 31, 2022 | -77,312.00 |
| Sep 30, 2022 | -55,891.00 |
| Jun 30, 2022 | -32,188.00 |
| Mar 31, 2022 | -29,484.00 |
| Dec 31, 2021 | -17,730.00 |
| Sep 30, 2021 | -7,299.00 |
| Jun 30, 2021 | -7,633.00 |